b.vukovic
Submits third-party assay reports on material purchased directly. Based in Valencia.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
7
n=7
Annotations
0
n=0
Median purity submitted
99.15%
n=7
Suppliers covered
7
n=7
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041335 | Semaglutide | WWB | WWB-2606-N3192 | Janoshik | 2026-Q3 | 99.15 | 4.27 | 98.9 | Buyer-sourced | 0 | PASS |
| AX-2026-043410 | CJC-1295 (no DAC) | WXT | WXT-2511-N3100 | Janoshik | 2026-Q1 | 97.52 | 3.03 | 105.4 | Buyer-sourced | 1 | FAIL |
| AX-2026-041411 | GHRP-6 | QYB | QYB-2602-X4422 | Kestrel | 2026-Q1 | 99.18 | 1.95 | 104.1 | Buyer-sourced | 0 | PASS |
| AX-2026-042402 | Retatrutide | Homopeptide | HOMO-2601-J3763 | Janoshik | 2026-Q1 | 99.39 | 4.43 | — | Buyer-sourced | 0 | PASS |
| AX-2025-020411 | Liraglutide | MKM | MKM-2508-P4928 | Nordanalyt | 2025-Q3 | 97.98 | 7.00 | — | Buyer-sourced | 0 | PASS |
| AX-2025-018744 | CJC-1295 (no DAC) | QSC | QSC-2411-D7855 | Janoshik | 2025-Q1 | 99.81 | 3.48 | — | Supplier-supplied | 0 | PASS |
| AX-2024-004877 | Tirzepatide | ERP | ERP-2406-E9182 | PeptideMeter | 2024-Q3 | 97.96 | 4.27 | — | Laboratory-retained | 0 | PASS |